Katrina’s practice focuses on a diverse range of corporate matters, including cross-border mergers and acquisitions, private equity investments, regulatory and compliance, and other general corporate matters.

Katrina has experience advising multinational companies, sovereign wealth funds, private equity investors, family offices, and start up entrepreneurs across various sectors including consumer goods and services, life sciences, and technology (including AgTech).Katrina is fluent in English, Cantonese and Mandarin.

Representative Matters

• Happiness Capital
• in its US$350,000 Series Seed investment in Kyomei, a company with innovative molecular farming technology to use plants to produce animal-identical proteins that replicate the taste and nutritional value of traditional meat.
• in connection with the US$10 million Series A minority investment in Botrista, a U.S.-based robotic barista automation solution provider.
• in connection with the US$4.7 million equity investment in NovoNutrients, a U.S.-based alternative proteins company that transforms CO2 emissions into high-value, low-cost proteins and additives for food and feed.
• Cayman Islands-incorporated and Taiwan-based The News Lens Co., Ltd. (TNL) in its proposed de-SPAC with Blue Ocean Acquisition Corporation (NASDAQ: BOCN), a publicly traded special purpose acquisition company, and its proposed listing on NASDAQ.  TNL is an independently owned international web media group with editions of its core “The News Lens” brand published in Taiwan, Hong Kong, ASEAN and Japan as well as an International (English) edition. 
• Ally Bridge Group in connection with numerous investments in various life sciences companies, including: 
• as lead investor in connection with the US$60 million Series F financing of Aerin Medical Inc., a medical technology company focused on the ear, nose and throat market providing non-invasive solutions for the treatment of chronic nasal conditions.
• as lead investor in connection with the US$62 million Series D financing of Mission Bio, Inc., a life science tools company focused on single cell genomics, proteomics and multi-omics solutions for oncology study and cell and gene therapy development.
• as lead investor in connection with the $101 million Series B financing of Endeavor BioMedicines, a clinical-stage biotechnology company targeting the core drivers of terminal diseases including oncology and fibrosis.
• as lead investor in connection with an oversubscribed US$265 Million Series B financing of Sonoma Biotherapeutics, a U.S. based life sciences company developing treatments for autoimmune and degenerative disease.
• in the follow-on US$100 million Series D financing of a company with a subscription-based application that connects patients with professional health coaches, nutritionists, exercise physiologists, nurses, and diabetes educators. 
• in a follow-on US$81 million equity investment in Rapid Micro Biosystems, Inc., a U.S. based medical product manufacturer. Including this latest financing, Rapid Micro Biosystems has raised over $340 million of equity for its expansion.
• in connection with the $200 million Series C investment of Transcarent, a new and different health and care experience company for employees of self-insured employers and their families.
• LeapXpert, a Hong Kong and US-based communications and messaging platform provider, in connection with its US$22 million Series A+ financing led by Rockefeller Asset Management. The investment also includes participation from Uncorrelated Ventures, the Partnership Fund for New York City, and a new strategic investor, as well as existing investors.

• Tencent Holdings Limited its US$46 million (JPY5 billion) acquisition of a majority stake in Wake Up Interactive Limited, together with its wholly-owned subsidiaries in Japan, Valhalla Game Studios Ltd. and Soleil Ltd., which produce video games and online entertainment. 

• LSE-listed Tate & Lyle PLC, a leading global provider of food and beverage ingredients and solutions,

  • in connection with its agreement to acquire Quantum Hi-Tech (Guangdong) Biological Co., Ltd, a leading prebiotic dietary fiber business in China, from ChemPartner Pharmatech Co., Ltd.
  • on its acquisition of Sweet Green Fields (SGF), a leading global stevia solutions business.
• Ping An Insurance (Group) Company of China Ltd. in its capital and strategic alliance with Shionogi & Co., Ltd. with a total value of US$780 million, which includes (i) subscription of a 2.05% voting stake in Shionogi and (ii) establishment of joint ventures in Shanghai and Hong Kong. Shionogi is a leading research-driven pharmaceutical company headquartered in Japan.
• Ascendent Automation (Cayman) Limited, an affiliate of Ascendent Capital Partners as one of the Joint Offerors, in its offer to privatize China Automation Group Limited (CAG) (0569.HK) by way of a Cayman scheme of arrangement for HK$391,998,649.50 (about US$50.06 million). Ascendent Capital Partners also provided a loan facility to the other joint offeror (being the controlling shareholder of CAG) for the purpose of the offer. CAG is a China-based company principally engaged in: (i) the provision of safety and critical control system and control valves specialized for petrochemical industries, along with related maintenance and engineering services; and (ii) hospital business in Suzhou, the PRC.
• SoftBank Vision Fund in connection with an investment totaling US$1.5 billion in Chehaoduo, a leading Chinese customer-to-customer auto retail services company that operates Guazi, an e-commerce platform focusing on second-hand car transactions, and Maodou, an e-commerce platform focusing on new car transactions.